Risedronate rapidly reduces vertebral fracture risk in postmenopausal women with established osteoporosis

被引：0
|
作者：
Roux, C
Miller, P
Gennari, C
Keller, M
Sorensen, O
Ritter-Hrncirik, C
Barton, I
Watts, N
机构：
来源：
ARTHRITIS AND RHEUMATISM | 1999年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1300
引用
收藏
页码：S287 / S287
页数：1
相关论文
共 50 条
  • [21] Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis
    Roux, C.
    Isaia, G.
    Andia, J. B. Cannata
    Devogelaer, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 681 - 681
  • [22] Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
    Masud, Tahir
    McClung, Michael
    Geusens, Piet
    CLINICAL INTERVENTIONS IN AGING, 2009, 4 : 445 - 449
  • [23] Vertebral fracture risk reduction with risedronate in postmenopausal women with osteoporosis: A meta-analysis of individual patient data
    Adachi, JD
    Li, Z
    Meredith, M
    Chesnut, CH
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S61 - S61
  • [24] Bazedoxifene reduces the risk of fracture in women with postmenopausal osteoporosis
    Nature Clinical Practice Rheumatology, 2008, 4 (11): : 566 - 566
  • [25] Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women
    Reginster, JY
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (02) : 121 - 122
  • [26] Risedronate rapidly reduces vertebral fracture risk in patients with varying degrees of osteoporotic severity
    Eastell, R
    Prendergast, J
    Molloy, M
    Adachi, J
    Miller, P
    Pack, S
    Watts, N
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S208 - S209
  • [27] Risedronate at both 2.5 mg and 5.0 mg daily doses reduces the risk of hip fracture in women with established osteoporosis
    McClung, Michael R.
    Purple, Christopher R.
    Zhou, Xiaojie
    Watts, Nelson
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S215 - S215
  • [28] The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
    Meunier, PJ
    Roux, C
    Seeman, E
    Ortolani, S
    Badurski, JE
    Spector, TD
    Cannata, J
    Balogh, A
    Lemmel, EM
    Pors-Nielsen, S
    Rizzoli, R
    Genant, HK
    Reginster, JY
    Graham, J
    Ng, KW
    Prince, R
    Prins, J
    Seeman, E
    Wark, J
    Reginster, JY
    Devogelaer, JP
    Kaufman, JM
    Raeman, F
    Ziekenhuis, JP
    Walravens, M
    Pors-Nielsen, S
    Beck-Nielsen, H
    Charles, P
    Sorensen, OH
    Meunier, PJ
    Aquino, JP
    Benhamou, C
    Blotman, F
    Bonidan, O
    Bourgeois, P
    Dehais, J
    Fardellone, P
    Kahan, A
    Kuntz, JL
    Marcelli, C
    Prost, A
    Vellas, B
    Weryha, G
    Lemmel, EM
    Felsenberg, D
    Hensen, J
    Kruse, HP
    Schmidt, W
    Semler, J
    Stucki, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (05) : 459 - 468
  • [29] Risedronate signficantly reduces hip fracture risk in elderly women with osteoporosis.
    Bensen, W
    Piette, F
    Ettinger, M
    Horlait, S
    DiMunno, O
    Silverman, S
    Bos, K
    Reginster, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S226 - S226
  • [30] Strontium ranelate reduces the risk of non vertebral fractures in women with postmenopausal osteoporosis
    Reginster, JY
    Lorenc, RS
    Spector, TD
    Benhamou, C
    Isaia, G
    Brixen, K
    Stucki, G
    Prins, J
    Walravens, M
    Cannata, JB
    De Chatel, R
    Meunier, PJ
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S51 - S52
12345